Steward Partners Investment Advisory’s Altimmune ALT Stock Holding History
Bought
Maintained
Sold
Other funds holding ALT
Steward Partners Investment Advisory's ALT Position: Q2 2026 in Review
Steward Partners Investment Advisory increased its Altimmune (ALT) stake by 5.9% in Q2 2026, buying an estimated $44.5K and bringing the position to 266,671 shares worth $811K. The position accounts for ﹤0.01% of the portfolio, ranked #1424.
Steward Partners Investment Advisory first reported a position in ALT in Q4 2023 and has held it in 11 quarters since. The position peaked at $886K in Q4 2025. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.
- Steward Partners Investment Advisory held 266,671 shares of Altimmune worth $811K as of Q2 2026.
- Steward Partners Investment Advisory bought 14,890 Altimmune shares in Q2 2026, an estimated $44.5K.
- Altimmune made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #1424 holding.
- Steward Partners Investment Advisory first reported a position in Altimmune in Q4 2023 and has held it in 11 quarters since.
- Steward Partners Investment Advisory's Altimmune position peaked at $886K in Q4 2025.
- 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.
Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.